Micron Biomedical

Atlanta, GA · Founded 2009 · Privately Held (backing)

Operator of a biopharmaceutical company intended to develop microneedle patches for influenza and polio vaccines. Micron Biomedical is based in Atlanta, GA and was founded in 2009. It was valued at $105 million at its later-stage round in Dec 2024, the last priced event on record. It has raised $32 million across 3 recorded rounds; the latest was a $15 million early-stage round in Dec 2024.

PMV mark · valuation
$105.0M
Oct 2026
Priced at
its later-stage round
Dec 2024
Total raised
$32.0M
Last round
Early Stage VC
Dec 2024
What is Micron Biomedical worth?
$105.0MPrivateMarketView mark · Oct 2026

Valued at $105.0M at its later-stage round, Dec 2024. Nothing has traded since.

Free account
More of Micron Biomedical with a free account
  • ·The complete investor list: 12 names
  • ·Watch Micron Biomedical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Micron Biomedical funding history

3 rounds
DateRoundRaisedPost-money
Dec 2024Early Stage VC$15.0M▮
Apr 2023Seed Round$3.0M▮
Nov 2022Early Stage VC$14.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Micron Biomedical valuation

Micron Biomedical was valued at $105 million at its later-stage round in Dec 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Micron Biomedical raised?

Micron Biomedical has raised $32 million across 3 recorded rounds since 2022. The largest was a $3 million seed round in Apr 2023; the most recent was a $15 million early-stage round in Dec 2024.

Micron Biomedical has filed 3 Form Ds with the SEC since 2022, most recently in Dec 2024 ($15 million sold to 3 investors).

How Micron Biomedical's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Micron Biomedical, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Micron Biomedical

What is Micron Biomedical worth?
Micron Biomedical is valued at $105.0M as of Oct 2026. Valued at $105.0M at its later-stage round, Dec 2024. Nothing has traded since.
How much has Micron Biomedical raised?
Micron Biomedical has raised $32.0M in total funding across 3 recorded rounds.
When did Micron Biomedical last raise?
Micron Biomedical last raised in Dec 2024 (Early Stage VC), raising $15.0M.